by Reuters | Jul 1, 2023 | Asia, Canada, Europe, Politics, Science, Technology, Top News
By Steve Gorman (Reuters) -A European-built orbital satellite was launched to space on Saturday from Florida on a mission to shed new light on the mysterious cosmic phenomena known as dark energy and dark matter, unseen forces scientists say account for 95% of the...
by Reuters | Jul 1, 2023 | Europe, Politics, Top News, US
By Olena Harmash (Reuters) – Ukraine has been publicly cautious in counting gains in a counteroffensive it launched this month to reclaim territory occupied by Russian forces, and on Friday its president and a U.S. general acknowledged that progress is measured...
by Reuters | Jul 1, 2023 | Asia, Business, Economy, Europe, Health, US
(Reuters) – Swiss drugmaker Sandoz said on Saturday it had launched a biosimilar version of AbbVie Inc’s big selling arthritis treatment Humira, adding to U.S. competition for the drug that started in January. The Novartis-owned company said its drug,...
by Reuters | Jun 30, 2023 | Business, Economy, Europe, Technology, US
(Reuters) – Nokia said on Friday it had signed a new long-term patent license agreement with Apple, as the current license between the companies expires at the end of 2023. While terms of the agreement remain confidential between the companies, it covers Nokia’s...
by Reuters | Jun 30, 2023 | Business, Canada, Europe
(Reuters) – Bausch + Lomb said on Friday it would acquire several Novartis eye-care products for $1.75 billion as their market grows, sending the company’s shares up over 8% in early trading. The deal includes acquisition of Novartis’...
by Reuters | Jun 27, 2023 | Business, Europe, Health, Top News, US
By Khushi Mandowara (Reuters) – U.S. health regulators on Tuesday declined to approve a higher-dose version of Regeneron Pharmaceuticals’ drug Eylea for treatment of a disease that is leading cause of blindness among the elderly, the company said as shares...
